USPTO serial 86982214
VIUM
Reviewed by CopyMark Law Group
Reg. 5215140Status 710
- Filing date
- Status date
- Registration date
- May 30, 2017
- Examiner
- BUTLER, MIDGE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with VIUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
RECURSION PHARMACEUTICALS, INC.
SALT LAKE CITY, UT
San Mateo, CA
San Mateo, CA
SAN MATEO, CA
SAN MATEO, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David P. Johnson
David P. Johnson Workman Nydegger60 East South TempleSuite 1000Salt Lake City, UT 84111Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Laboratory analysis in the field of genotyping and phenotyping of animals, laboratory animal scientific research and testing; Laboratory research in the field of genotyping and phenotyping of animals; Scientific laboratory services; Scientific research and development; Scientific research consulting in the field of genotyping and phenotyping of animals; laboratory animal scientific research and testing; research and development of pharmaceuticals and biologics; scientific testing of pharmaceuticals and biologics; biopharmaceutical research design and scientific testing services; product safety testing for pharmaceuticals, biopharmaceuticals, and biologics; toxicological safety testing services for pharmaceuticals; animal medical research and testing services for the purpose of medical research; research and development of pharmaceuticals, biotechnology, and biochemicals; platform as a service (PAAS) featuring computer software platforms for conducting preclinical research in the field of animal scientific research and testing and development of pharmaceuticals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing non-clinical trials and studies on pharmaceuticals for others; scientific consulting services for others in the field of non-clinical trials and studies on pharmaceuticals; collection, calibration, analysis and reporting of medical and scientific research data in connection with non-clinical trials and studies on pharmaceuticals; scientific research and analysis in the fields of bioinformatics, biomarkers and phenotyping; computer hardware and software design; development, updating and maintenance of software and databases; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical development studies; providing online computer databases in the fields of research and development of pharmaceuticals, biotechnology, and biochemicals; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from non-clinical trials and studies on pharmaceuticals; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals; providing online non-downloadable software for designing, conducting, analyzing, and reporting animal studies | SECTION 8 - CANCELLED | May 4, 2016 |
| 044 | Laboratory animal breeding and preconditioning; genetic testing of animals; consulting services in the field of laboratory animal caretaking; surgical services; collection, organization, analysis, and reporting of medical data in connection with non-clinical trials and studies on pharmaceuticals | SECTION 8 - CANCELLED | May 4, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by RECURSION PHARMACEUTICALS, INC.
- Other trademarks owned by Mousera, Inc.
- Other trademarks owned by Mousera, Inc.
- Other trademarks owned by VIUM, INC.
- Other trademarks owned by VIUM, INC.
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named VIUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 15, 2023 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| May 30, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 19, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 6, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 6, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 11, 2019 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED | — |
| Apr 11, 2019 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 30, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 22, 2017 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 21, 2017 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 21, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 20, 2017 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 20, 2017 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Apr 20, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 20, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 30, 2017 | IUAF | USE AMENDMENT FILED | — |
| Mar 30, 2017 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Mar 30, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 30, 2017 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Mar 30, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 30, 2017 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 4, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 10, 2016 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 9, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 9, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 20, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 5, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 26, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 23, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 22, 2016 | ALIE | ASSIGNED TO LIE | — |
| Jun 15, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 2, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 25, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 12, 2016 | NWAP | NEW APPLICATION ENTERED | — |